Works matching IS 15228517 AND DT 2017 AND VI 19 AND IP 11
Results: 21
Prognostic awareness, prognostic communication, and cognitive function in patients with malignant glioma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1532, doi. 10.1093/neuonc/nox117
- By:
- Publication type:
- Article
Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1542, doi. 10.1093/neuonc/nox109
- By:
- Publication type:
- Article
Phase II trial of dacomitinib, a pan‒human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1522, doi. 10.1093/neuonc/nox105
- By:
- Publication type:
- Article
Global incidence of malignant brain and other central nervous system tumors by histology, 2003–2007.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1553, doi. 10.1093/neuonc/nox091
- By:
- Publication type:
- Article
Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1511, doi. 10.1093/neuonc/nox077
- By:
- Publication type:
- Article
Resolving Intertumor Heterogeneity Within Medulloblastoma Subgroups.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1434, doi. 10.1093/neuonc/nox185
- By:
- Publication type:
- Article
Uncovering Evolutionary Relationships Between Transcriptional Subtypes and Infiltrating Immune Cells in Glioblastoma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1433, doi. 10.1093/neuonc/nox185
- By:
- Publication type:
- Article
Characterizing and Combating EGFR Inhibitor Resistance in Glioblastoma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1433, doi. 10.1093/neuonc/nox185
- By:
- Publication type:
- Article
Efficacy of Anti-PD-1 Therapy in Patients With Melanoma Brain Metastases.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1432, doi. 10.1093/neuonc/nox185
- By:
- Publication type:
- Article
The Clinical Value of ATRX and TERT Mutations in Diffuse Adult Gliomas.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1432, doi. 10.1093/neuonc/nox185
- By:
- Publication type:
- Article
Meeting Update--World Federation of Neuro-Oncology Societies (WFNOS) Meeting 2017.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1457, doi. 10.1093/neuonc/nox184
- By:
- Publication type:
- Article
EGFRvIII vaccine in glioblastoma--InACT-IVe or not ReACTive enough?
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1425, doi. 10.1093/neuonc/nox167
- By:
- Publication type:
- Article
ID(H)entifying checkpoint inhibitor candidates among diffuse glioma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1427, doi. 10.1093/neuonc/nox145
- By:
- Publication type:
- Article
Caddyshack therapeutics: overcoming glioblastoma adaptation.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1429, doi. 10.1093/neuonc/nox096
- By:
- Publication type:
- Article
BAP1 mutations in high-grade meningioma: implications for patient care.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1447, doi. 10.1093/neuonc/nox094
- By:
- Publication type:
- Article
Prognostic significance of preoperative neutrophilia on recurrence-free survival in meningioma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1503, doi. 10.1093/neuonc/nox089
- By:
- Publication type:
- Article
Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1494, doi. 10.1093/neuonc/nox085
- By:
- Publication type:
- Article
The contribution of tumor-associated macrophages in glioma neo-angiogenesis and implications for anti-angiogenic strategies.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1435, doi. 10.1093/neuonc/nox081
- By:
- Publication type:
- Article
Correlation of immune phenotype with IDH mutation in diffuse glioma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1460, doi. 10.1093/neuonc/nox054
- By:
- Publication type:
- Article
Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1481, doi. 10.1093/neuonc/nox052
- By:
- Publication type:
- Article
Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1469, doi. 10.1093/neuonc/nox044
- By:
- Publication type:
- Article